Nanjing Vazyme Biotech Co., Ltd. (688105.SS)
CNY 23.21
(-1.9%)
CNY 23.21
(-1.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 198.4 Million | 735.16 Million | 616.8 Million | 803.55 Million | 15.2 Million | -3.99 Million |
| Net Income | -70.95 Million | 593.5 Million | 678.28 Million | 821.72 Million | 25.79 Million | 1.03 Million |
| Depreciation & Amortization | 235.63 Million | 122.09 Million | 55.27 Million | 13.72 Million | 7.21 Million | 4.39 Million |
| Deferred income taxes | -49.06 Million | -35.04 Million | -15 Million | 18.83 Million | -12.5 Million | -6.67 Million |
| Stock-based compensation | 19.07 Million | 7.37 Million | 7.46 Million | 10.61 Million | 5.29 Million | 6.27 Million |
| Change in working capital | -100.83 Million | -657.18 Million | -183.36 Million | -104.49 Million | -34.55 Million | -22.23 Million |
| Other non-cash items | 755.73 Million | 704.41 Million | 74.14 Million | 43.14 Million | 23.95 Million | 12.8 Million |
| Investing Cash Flow | -959.56 Million | -952.43 Million | -1.42 Billion | -933.03 Million | 12.19 Million | -56.22 Million |
| Investments in PPE | -232.9 Million | -962.86 Million | -261.96 Million | -152.54 Million | -19.88 Million | -32.13 Million |
| Acquisitions | -17.12 Thousand | -117.92 Million | 2.72 Million | 152.71 Million | 19.91 Million | - |
| Investment purchases | -6 Billion | -9.16 Billion | -6.5 Billion | -3.99 Billion | -209.95 Million | -102.9 Million |
| Sales/Maturities of investments | 5.27 Billion | 9.27 Billion | 5.33 Billion | 3.21 Billion | 241.98 Million | 78.75 Million |
| Other Investing Activities | -667.74 Million | 15.58 Million | 0.63 | -152.54 Million | -19.88 Million | 53.72 Thousand |
| Financing Cash Flow | 263.3 Million | 79.05 Million | 2.06 Billion | 261.2 Million | 5.07 Million | 32.68 Million |
| Debt repayment | -822.21 Million | -156.4 Million | -39.55 Million | -64 Million | -35.19 Million | -10.38 Million |
| Dividends payments | -500.01 Million | -120 Million | -4.44 Million | -1.45 Million | -1.25 Million | -868.46 Thousand |
| Common Stock Repurchased | -20.01 Million | - | -2.11 Billion | -297.14 Million | - | - |
| Common Stock Issuance | - | - | 2.11 Billion | 297.14 Million | - | - |
| Other Financing Activities | -32.75 Million | 367.69 Million | 2.11 Billion | 326.65 Million | 41.51 Million | 43.94 Million |
| Accounts receivables | 534.67 Million | -682.89 Million | -133.2 Million | -164.36 Million | -32.81 Million | -22.23 Million |
| Accounts payables | -511.13 Million | 464.57 Million | 113.78 Million | 169.23 Million | 37.29 Million | 19.66 Million |
| Inventory | -124.37 Million | -403.82 Million | -148.94 Million | -128.2 Million | -26.51 Million | -12.97 Million |
| Other working capital | 25.27 Million | -35.04 Million | -15 Million | 18.83 Million | -12.5 Million | -9.25 Million |
| Cash at beginning of period | 1.54 Billion | 1.47 Billion | 221.6 Million | 93.77 Million | 61.28 Million | 88.8 Million |
| Cash at end of period | 1.96 Billion | 1.34 Billion | 1.47 Billion | 221.6 Million | 93.77 Million | 61.28 Million |
| Capital Expenditure | -232.9 Million | -962.86 Million | -261.96 Million | -152.54 Million | -19.88 Million | -32.13 Million |
| Effect of forex changes on cash | 1.46 Million | 5.04 Million | -2.31 Million | -3.89 Million | 18.95 Thousand | 15.3 Thousand |
| Net cash flow / Change in cash | 422.28 Million | -133.17 Million | 1.25 Billion | 127.82 Million | 32.48 Million | -27.52 Million |
| Free Cash Flow | -34.49 Million | -227.69 Million | 354.84 Million | 651.01 Million | -4.67 Million | -36.13 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.99 Million | 10.94 Million | 5.21 Million | -70.95 Million | 5.43 Million | 4.7 Million |
| Depreciation & Amortization | - | 53.28 Million | 53.28 Million | 235.63 Million | 55.79 Million | -76.26 Million |
| Deferred income taxes | 10.41 Million | - | - | -49.06 Million | - | 533.92 Million |
| Stock-based compensation | - | 38.03 Million | - | 19.07 Million | 19.07 Million | -3.73 Million |
| Change in working capital | - | -144.79 Million | - | -100.83 Million | 435.57 Million | -466.46 Million |
| Other non-cash items | -29.17 Million | 61.87 Million | -79.14 Million | 755.73 Million | 236.98 Million | -55.53 Million |
| Investing Cash Flow | -353.22 Million | 58.09 Million | 469.49 Million | -959.56 Million | -19.77 Million | -940.62 Million |
| Investments in PPE | -30.34 Million | -12.6 Million | -29.66 Million | -232.9 Million | 7.71 Million | -66.89 Million |
| Acquisitions | 306.68 Thousand | 170.73 Thousand | 1.13 Million | -17.12 Thousand | -9.53 Million | 17.83 Million |
| Investment purchases | -1.53 Billion | -1.94 Billion | -956.83 Million | -6 Billion | -1.92 Billion | -1.84 Billion |
| Sales/Maturities of investments | 1.2 Billion | 2.01 Billion | 1.45 Billion | 5.27 Billion | 1.9 Billion | 966.5 Million |
| Other Investing Activities | 306.68 Thousand | 82.98 Million | 506.72 Million | -667.74 Million | 1.06 Million | -13.49 Million |
| Financing Cash Flow | -64.9 Million | -467.93 Million | -334.73 Million | 263.3 Million | -144.97 Million | 64.73 Million |
| Debt repayment | -26.82 Million | -414.49 Million | -269.94 Million | -822.21 Million | -124.4 Million | -200 Million |
| Dividends payments | -34.55 Million | -9.82 Million | -7.9 Million | -500.01 Million | -9.79 Million | -8.93 Million |
| Common Stock Repurchased | - | -100.02 Million | - | -20.01 Million | -20.01 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.52 Million | -52.96 Million | -64.79 Million | -32.75 Million | 505.58 Million | 273.67 Million |
| Accounts receivables | - | -150.67 Million | - | 534.67 Million | 534.67 Million | -597.23 Million |
| Accounts payables | - | - | - | -511.13 Million | - | - |
| Inventory | - | -26.81 Million | - | -124.37 Million | -124.37 Million | 130.77 Million |
| Other working capital | - | 32.69 Million | - | 25.27 Million | 25.27 Million | -3.73 Million |
| Cash at beginning of period | 517.42 Million | 1.36 Billion | 1.96 Billion | 1.54 Billion | 1.89 Billion | 1.76 Billion |
| Cash at end of period | 74.98 Million | 541.92 Million | 1.36 Billion | 1.96 Billion | 1.96 Billion | 827.36 Million |
| Capital Expenditure | -30.34 Million | -12.6 Million | -29.66 Million | -232.9 Million | 7.71 Million | -66.89 Million |
| Effect of forex changes on cash | 1.43 Million | -1.11 Million | -160.42 Thousand | 1.46 Million | -1.05 Million | -552.2 Thousand |
| Net cash flow / Change in cash | -442.43 Million | -822.74 Million | -602.21 Million | 422.28 Million | 72.12 Million | -939.81 Million |
| Free Cash Flow | -47.1 Million | 6.92 Million | -103.59 Million | -34.49 Million | 194.34 Million | -130.25 Million |
CHKEL
7939
EMX
2340
EPAC
3164